Literature DB >> 9371634

Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.

R Demaimay1, K T Adjou, V Beringue, S Demart, C I Lasmézas, J P Deslys, M Seman, D Dormont.   

Abstract

Amphotericin B (AmB) is one of the few drugs able to prolong survival times in experimental scrapie and delays the accumulation of PrPres, a specific marker of this disease in the brain in vivo. Previous reports showed that the AmB effect is observed only if the drug is administered around the time of infection. In the present study, intracerebrally infected mice were treated with AmB or one of its derivatives, MS-8209, between 80 and 140 days postinoculation. We observed an increased incubation time and a delay in PrPres accumulation and glial fibrillary acidic protein gene expression. Treatment starting at 80 days postinoculation was as efficient as long-term treatment starting the day of inoculation. Our results indicate that polyene antibiotics may interfere, throughout the course of the experimental disease, with the propagation of the scrapie agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371634      PMCID: PMC230278     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie.

Authors:  K T Adjou; R Demaimay; C Lasmezas; J P Deslys; M Seman; D Dormont
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

2.  Congo red prolongs the incubation period in scrapie-infected hamsters.

Authors:  L Ingrosso; A Ladogana; M Pocchiari
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

3.  Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics.

Authors:  K T Adjou; R Demaimay; C I Lasmézas; M Seman; J P Deslys; D Dormont
Journal:  Res Virol       Date:  1996 Jul-Aug

4.  Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection.

Authors:  D McKenzie; J Kaczkowski; R Marsh; J Aiken
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.

Authors:  Y Tokuda; M Tsuji; M Yamazaki; S Kimura; S Abe; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

6.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

7.  The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.

Authors:  A Vertut-Doï; S I Ohnishi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

8.  Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.

Authors:  D R Brown; B Schmidt; H A Kretzschmar
Journal:  Nature       Date:  1996-03-28       Impact factor: 49.962

9.  Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures.

Authors:  W E Müller; H Ushijima; H C Schröder; J M Forrest; W F Schatton; P G Rytik; M Heffner-Lauc
Journal:  Eur J Pharmacol       Date:  1993-08-15       Impact factor: 4.432

10.  Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.

Authors:  A Taraboulos; M Scott; A Semenov; D Avrahami; L Laszlo; S B Prusiner; D Avraham
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  21 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.

Authors:  A Mangé; N Nishida; O Milhavet; H E McMahon; D Casanova; S Lehmann
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.

Authors:  V Beringue; K T Adjou; F Lamoury; T Maignien; J P Deslys; R Race; D Dormont
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Hidefumi Furuoka; Motohiro Horiuchi
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

5.  Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.

Authors:  James A Carroll; Brent Race; Katie Phillips; James F Striebel; Bruce Chesebro
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

Review 6.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 7.  Therapies for human prion diseases.

Authors:  Peter K Panegyres; Elizabeth Armari
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

8.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.

Authors:  Katsumi Doh-ura; Kensuke Ishikawa; Ikuko Murakami-Kubo; Kensuke Sasaki; Shirou Mohri; Richard Race; Toru Iwaki
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.

Authors:  Jens Wagner; Sergey Ryazanov; Andrei Leonov; Johannes Levin; Song Shi; Felix Schmidt; Catharina Prix; Francisco Pan-Montojo; Uwe Bertsch; Gerda Mitteregger-Kretzschmar; Markus Geissen; Martin Eiden; Fabienne Leidel; Thomas Hirschberger; Andreas A Deeg; Julian J Krauth; Wolfgang Zinth; Paul Tavan; Jens Pilger; Markus Zweckstetter; Tobias Frank; Mathias Bähr; Jochen H Weishaupt; Manfred Uhr; Henning Urlaub; Ulrike Teichmann; Matthias Samwer; Kai Bötzel; Martin Groschup; Hans Kretzschmar; Christian Griesinger; Armin Giese
Journal:  Acta Neuropathol       Date:  2013-04-19       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.